Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 1;114(11):513–524. doi: 10.1177/01410768211052589

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Royal Society of Medicine

This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 3. — Hospitalisations* and deaths averted by COVID-19 vaccination in adolescents at different incidence levels. (a and b) The number of hospitalisations,* and deaths averted as a function of case incidence among 12–17 year olds over a 16-week period. For hospitalisations, we represent these separately for boys and girls to account for the differing rate of vaccine-related myocarditis. Myocarditis here refers to both vaccine related myocarditis and pericarditis. *Note: Total hospitalised considers hospitalisations from COVID-19 and vaccine-related myocarditis/pericarditis (assuming a worst-case scenario that all cases of myocarditis are hospitalised).